Compare MSN & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSN | ACON |
|---|---|---|
| Founded | 1948 | 2008 |
| Country | United States | United States |
| Employees | N/A | 11 |
| Industry | Consumer Electronics/Appliances | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 7.4M |
| IPO Year | 1995 | N/A |
| Metric | MSN | ACON |
|---|---|---|
| Price | $0.36 | $2.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 31.6K | ★ 55.4K |
| Earning Date | 02-17-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $77,829,000.00 | N/A |
| Revenue This Year | N/A | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.32 | $2.34 |
| 52 Week High | $0.85 | $12.03 |
| Indicator | MSN | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 42.86 |
| Support Level | $0.35 | $2.38 |
| Resistance Level | $0.42 | $3.54 |
| Average True Range (ATR) | 0.02 | 0.18 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 46.72 | 46.40 |
Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.